| # | Drug | Count |
|---|---|---|
| 0 | PIOGLITAZONE | 44 |
| 1 | RANITIDINE | 25 |
| 2 | ROSUVASTATIN | 17 |
| 3 | METFORMIN | 15 |
| 4 | METFORMIN ER 500 MG | 15 |
| 5 | METFORMIN ER 750 MG | 15 |
| 6 | MYCOPHENOLATE MOFETIL | 15 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 15 |
| 8 | TACROLIMUS | 15 |
| 9 | ATORVASTATIN CALCIUM | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VALRUBICIN | 1 | 0.0056 |
| 1 | GLYCERINE | 1 | 0.0031 |
| 2 | FENOFIBRIC ACID | 2 | 0.0026 |
| 3 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 4 | ERDAFITINIB | 2 | 0.0016 |
| 5 | SODIUM HYALURONATE | 1 | 0.0012 |
| 6 | BACILLUS CALMETTE-GUERIN | 2 | 0.0011 |
| 7 | PIOGLITAZONE | 44 | 0.0010 |
| 8 | FLUTAMIDE | 1 | 0.0010 |
| 9 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 3 | Proton Pump Inhibitor [EPC] | 16 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 15 |
| 5 | Benzodiazepine [EPC] | 14 |
| 6 | Insulin Analog [EPC] | 14 |
| 7 | Kinase Inhibitor [EPC] | 13 |
| 8 | Calcium Channel Blocker [EPC] | 12 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 4 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 5 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 11 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 7 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |